As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.

Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

23, 2024 — A new gene ... of Alzheimer's disease in a subset of people. It is believed most humans are ... First Successful Clinical Trial of VU319 Brings Alzheimer's Treatment One Step Closer ...

This specifically involved distinguishing between Alzheimer's disease, the most common form of dementia, and Lewy body ...

Revised guidelines for amyloid and tau positron emission tomography for Alzheimer’s disease and dementia state these tests ...

Genetic differences that contribute to how long a person will live and their risk of Alzheimer's disease have been identified ...

There is a potential link between Alzheimer's disease and the herpes simplex virus-1 (HSV-1), which is a common cause for ...

Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.

A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...